Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No need to call people names on this board. I would venture to say most of us have graduated from elementary school.
I tend to have differing opinions on Nader.
We have in 2019
-HIV combo fast track designation
-Filed 1/3 of BLA for Combo Therapy
-Working on Monotherapy pivotal trial (first ever for any HIV product)
-FDA accepted Colorectal phase 2 trial
-FDA accepted TNBC phase 1b/2 trials also started with emergency and trial injections
-FDA accepted phase 2 NASH trial
-Deal with Samsung Biologics to manufacture product with payments not due until next year
-GvHD first injection on the way
-Got a small business waiver to avoid 1 million payment to FDA for application fees
- Made a deal with IncellDx to sell them old throw away product that can be used for CCR5 tests
- Working with Thai Red Cross and Dr. Jonah Sacha for Prep and Cure (being funded by the participants, CYDY only providing the drug)
All this on a college dorm ramen noodle budget. Do tell me with your knowledge of running start up biotechs, how you would get more things done with less money and how you would strong arm the FDA into approving your product so much faster.
Did we hear a completed financing deal today? nope. Did we want one? I sure did. Are talks still ongoing? I think so, I don't think Nader is lying about that. He made it known perhaps to us, or anyone else listening in, he's not taking lowball offers just because the share price is low.
Still long CYDY, good luck to you. Personally I don't think its a bad thing to take profits everyone once in awhile if thats your game. All profit is good profit, and profit is why we invest. (at least thats why I invest)
Oh no, not another piece of happy news on a Friday. Haven't you read the posts by the biotech experts on this board. Anything on a Friday is harbingers of doom. Practically guarantees that the last dime Cytodyn has was spent on this conference call to tell us all that they have filed bankruptcy.
On a completely separate note. Congrats Dr. NP!
Amen MrGuru,
I know there are those here that are trying to talk me off the ledge of diving too deep into the abyss of cydy shareland and I applaud their efforts. But the addiction to the roller coaster is real and it's spectacular. I'm buckled up and ready to hear Thursdays non-binding deal (which I assume will be binding post approval).
Glad to have someone like yourself join me in my gluttony of share price punishment. When it finally goes under as various investing afficianados have been prophesying for some time... I'll just think of it as I purchased thousands of 40 cent cans of cheap soda...and drank them all with nothing but a high fructose gut to show for it.
RIP cydy, we hardly knew ye.
Common ground we have. I can't stand cats myself.
You are absolutely 100% without a doubt correct. If I was half the investor you are I would totally take out a monster loan to short this dog all the way to zero. You totally should, there is no possible way your keen insight could be wrong about this scam of a stock.
Unfortunately I'm only a novice naive investor following the bagpiping CEO and the other sheeple longs heading to slaughter. Whoa is me. Someday I'll get smarter but today is not that day.
I do agree that the 8 cancer IND's being left off the latest slide show is capital related. Also NP said they need 10-15 million to get to the end of the year. With 4 months left that would suggest their cash burn dropped a fair sum. Maybe getting rid of the non-producing Florida office saved some $$.
I cannot speak to the how or why of Pestell and the funding he was trying to get per the letter. I have not heard the other side to see if they viewed what he was doing as undermining the CEO, the terms were perhaps unfavorable, or what the deal was. Should know within a few weeks the other sides perspective. Of course knowing which side is telling the truth will be speculation on anyones part because we weren't there to witness any of it. The truth will probably be somewhere in the middle of both statements.
I think the removal of the 8 indications was a good move. HIV is the indication that is closest to approval and what will get them revenue so they can pick back up on the cancer indications once they have some cash flow.
I think NP said with the colorectoral IND that they took it to phase 2 protocol filing and won't spend another dime on it unless they sign a partnership deal. (I believe it was the interview after the press release if you want to fact check me, I don't remember everything verbatim)
Makes sense to me, they are cash strapped, and todays video didn't do anything to say different, with NP saying that the 10 million or so needed until the end of the year wouldn't be a problem to get, but it sounded like a dilutionary round to me.
Not everything is all unicorns and butterflies, but I don't think its bankruptcy yet either. Per the 10K, I think the had 2m+ cash on hand at the end of June, plus the TO rounds which netted around 15 million total(I think), so unless the July/August burn rate was 8.5 million a month (which I don't believe it is), we still have some cash left.
The BLA approval will take the most cash with a 5 million payment to progenics.
Time will tell.
Good luck investing!
Certainly an interesting take and perspective but of course not to be taken as fact, it is all your speculation which is fine(pun intended).
You could also see it as, RP was brought on for the oncology studies, and in the almost 9 months or so of his tenure. All we got were mouse xenografts showing progress in mice(excellent results mind you). CYDY does not have alot of money to burn so RP was notified that his funding was going to be cut to go towards HIV which is closer to approval and chance at revenue than any cancer indication. A small biotech needs to make tough choices like that when funding is limited. If the feet weren't dragging on the cancer side, perhaps CYDY could have kept going.
Its also possible that RP was negotiating terms with the Regeneron or Goldman Sachs without NP's knowledge to verify the terms were favorable. Undercutting upper mgmt is a no no in most people's books, whether you respect them or not.
I do know that within less than 2 months after RP was terminated, the first TNBC patient was injected, and the colectoral pivotal trial was also filed. Strange? The head of oncology gives us a mouse xenograft in 9 months of work...but 2 months of NP pushing buttons and we get results. Hmmmm. OK, probably a fluke, except that in one interview while RP was still with the company NP admitted in an interview that they had zero patients signed up at any of the trial sites.
It does seem RP is not going after much other than salary, his right to keep 8 mill shares, and to change the termination for cause part instead to giving him a chance to "resign" or make it look like better circumstances.
I don't doubt there will be 2 stories to this, and both may have some half truths or things from a certain perspective. I see you have chosen yours already before the story from the other side came out. It fits your negative slant which you cling to dearly at every turn of events. Totally ok with that everyone is different and has an opinion.
These takes are my own. I wouldn't take any of them as fact or suggest they are. I respect the knowledge RP brought to this company in shedding light for the oncology space. He is owed that much at least. I will let the "he said, we said" battle go on in court and watch with interest.
In the mean time business will go on as usual for CYDY. Pretty sure they aren't folding up shop for something they probably expected.
Good luck investing all!! Hope these distractions don't get in the way of patients getting a drug that can help them achieve a better life.
Are you thinking that's going to be NPs raise this year after the shareholder meeting and vote?
You are absolutely not wrong. He has mentioned many possible deals that have never come to fruition.
But i would tread lightly on the short side so as not to get caught with my shorts down. I think Dr rae the guy they brought in to make deals is probably doing a better job of negotiating favorable terms.
Plus that other article you just posted may be pushing other big pharmas to catch up with more than just pill regimens in the HIV world.
There will be competition, but not everyone will want the viiv treatment. Not everyone will want leronlimab. Not everyone wants a Toyota even though their quality is generally high.
Good luck investing and thanks for the viiv jnj post. Have to keep an eye on the competition.
Newest interview here. You may not have to worry about that dilution.
Somewhere in the middle and near the very end NP reiterates that a license deal is very close with significant money to get them to the revenue finish line.
https://audioboom.com/posts/7348426-cytodyn-joins-the-stock-day-podcast-to-discuss-phase-3-trials-for-their-hiv-program
If you're not an NP fan and assume he's lying if his mouth is moving, then you will most likely disregard...but if you're shorting and wrong waiting for 20-30 cents to hit, don't say NP didn't warn you.
I picked Schwab(was share builder until E-Trade bought their investment division) mostly I chose them because they have index funds I can invest in for my kids for as little as 1 dollar. Turns out to be a good change for me because sharebuilder charges exhorbitant amounts for penny stocks. Schwab is 4.95 no matter the stock price. I debated fidelity too they seemed good too but the dollar investing was the winning feature to help teach my kids how to invest when they have no interest in researching like I do.
Football season is back. Fantasy football and stocks, my 2 favorite past times.
I would think patient confidentiality would keep them from divulging such info. If Charlie were to freely give that info out, no biggie, but I don't think Cytodyn or any hospital is allowed to give that out without permission. (Unless he were to officially be some sort of spokesperson)
Your concerns are not unfounded, there will be competition and I know gild won't rest on it's laurels either. I so think there will be a decent market for leronlimab because of our current culture of convenience.
I personally wouldn't do the monthly Dr visit because then I'm consistently havito use vacation time or take off of work to go to the hospital. There's commute time, the wait room(I've never gotten right in to see the Dr) and all told it may take half a day per month even though the actual process is one hour.
Leronlimab I can probably have shipped to my home, it's not a daily pills, but a once per week deal.
Will it be for everyone? No. But I think it will appeal to many. So not just the safety but convenience in our society makes me think it has a good potential market. Remember when 3d tvs were all the rage but who wanted to watch TV with those glasses?
So some people will stick to pills since they dont like needles, some may do the monthly because they like the longevity of only once a month and some will prefer the self administered injection weekly.
Yes around the 17 minute mark on the moneytalkstation link posted.
He said they have one "in hand".
Now we don't know how that 250 million is. Is that in total like 50 million up front and 200 million after hitting a couple milestones(like BLA approval) or what. We don't know any licensing revenue percentages or indications either, but that kind of money would definitely get them to revenue upon approval.
Once again everything depends on the terms, but a better number out there than the 20-40 million chinese deal they mentioned in May? I think.
I think that's the one thing positive and negative investors in CYDY can agree on is that for this ladies sake and of her family, that leronlimab turns out to be the drug most of us think it can be and save some lives.
You make me laugh. Per the logic you present here are some other things not mentioned in the article(about FDA waiving fee) so that means they may not happen this year as well.
Winter
NP getting paid a salary
The new star wars movie
More presidential candidate debates
Happy investing, and cheer up the stock has climbed back up to 45 cents. Since you profess to be holding the stock and only want the best for cydy. That's something to cheer about.
you can still find the croi poster at the croi site
https://www.croiconference.org/sites/default/files/posters-2019/1430_Dhody_0486.pdf
Yeah. I know. That was my attempt at humor. I'm surprised some of people that lean more towards the negative persuasion didn't jump on that phrase saying that leronlimab was a "killer". Just having some fun, life is too short to be negative all the time. I like taking risks and am not emotionally tied to money. It's only a tool that helps provide wants and needs. Since I'm doing ok without my cydy investment I can pretend like I don't even have that money. If it hits great, if not, oh well on to other investments. Good luck to all!
Actually I'm kind of surprised more negative posters didn't jump on the statement by Dr. Lalezari like they did when NP slipped with his "1st Qtr approval 2nd 'year' revenue" even though 1st qtr approval, 2nd qtr revenue is more consistent with EVERY other interview he has had in the recent past as he tried to zip through all the information.
Dr. Lalezari said the drug is a killer...sell sell sell it kills people.
Lets take every word verbatim without listening to context. No one ever says the wrong word, or uses figurative language.
What if Boston Life was looking for new treatments for some of their customers. He was trying to verify if they had signed the agreement with Northwestern??...perhaps they will help recruit patients for TNBC by referring them to something that may be cheaper and better than the treatment their customer is taking now?
https://www.thebalancecareers.com/termination-for-cause-1918274
I know some people will stick to the NP vs RP narrative because it fits their bias view. I lean towards positive I admit so l decided to look up termination for cause. From the posted link it has to be pretty bad and almost immediate. We're not talking delayed TNBC, this is like harassment of employees or vendors, threats, falsifying records, or surfing "unprofessional" sites on company assets.
Extreme insubordination is listed so it's still a possibility that the Tiff between RP and NP grew. We may never know. If that is the case then NP took the high road in the video today.
You are not wrong however if pestell got caught doing something he shouldn't I don't think he'll want it brought to light in a court of law. If it was infighting over company direction or something like that, then we may have issues.
*the 8K filing on July 15
Perhaps we now know what the 8K with Dr. Welch and Dr. Kelly consulting fees are for now.
Safe travels! I admit it was fun writing that response.
I bow to your superior intellect oh mighty investing genius. You were able to foretell a mighty drop of one penny and gloat from your throne on high as we cydy peasants flounder for answers and search for crumbs in dumpsters. Please let us know more of your omnipotence and warn us of all the stocks that will suffer this horrific one cent plummet.
I anxiously await with bated breath as the next story of your infinite warnings saves us all from doom. Thank you. I don't know where my portfolio would be without you.
You are absolutely not a fool...unless most of us here are. Even those more hesitant and less optimistic here agree the science is very solid. I believe that is why we are in this. (It's why I am, this thing seems safer than even some over the counter drugs).
Our biggest risk is execution of management to:
1. Get FDA approval
2. Acquire enough funds(hopefully sans dilution) to keep the lights on and get to revenue.
3. Get revenue. Even when we get approval we have to get the word out there that a safer option exists. If no one knows...no one buys. (or people afraid of needles...they will probably stick with pills)
4. Post revenue we have to get enough revenue to pay any progenics royalties, Samsung manufacturing, and have some left over to further the many cancer, gvhd, nash trials we have on the current burners.
Getting to revenue will be good but profits may be further out, hopefully the revenue is enough to self fund the other projects. Still a long road ahead but promising.
Never said anything about Steve Jobs. Nor did I say NP was either of these gentlemen. I'm saying I don't think the missed deadlines and financials are the main culprit(used TSLA as comparison). Clearly they don't help. Jobs appeared to be a shrewd business man who had a handle on figuring out what the public wanted before they knew they wanted it. Very good visionary. Musk seems more scatter brained and impulsive speaking before thinking things through, throwing out robotaxis or anything to drum up excitement for his company. Very good at coming up with crazy ideas for the future. Leadership qualities questionable.(I don't believe Jobs ever smoked pot in a public interview)
Clearly each company has revenue which cydy does not, and experience where NP does not.
I do have a more optimistic view for cydy at this point in time. I think most is founded on expectations that the drug gets approved. I do caveat that with the fact I waited until February to invest. So my patience isn't as thin as some here.
When the stock pops back to 50 cents I won't be doing any victory laps, but when it drops down to the 38-40 cent range I'm not throwing in the towel. Trying to keep emotion out and facts and fundamentals be my guide.
Happy investing, sounds like your other investments doing well. All profit is good profit.
I actually think risk is a little higher than that. The OTC is a tough Hill to climb. We are seeing that play out right now. Funding harder to come by and timelines being pushed back. Despite that I remain optimistic, but keep a close eye on signs of possible last ditch desperate attempts to raise capital.
Personally I think the only things holding cydy back are lack of public knowledge and being on the OTC. The detractors can spout off all day about lies, missed deadlines, a pompous CEO that makes outrageous claims /promises and breaks them while having a horrible financial situation. If that was the case, then Tesla would also be a 40 cent stock.
Revenue, license deals, and exposure are what cydy needs. Right now lack of exposure is a blessing and a curse. We know what the drug can do so we pile on the shares(for those invested). Not alot of people know the story and science behind so a few new people throw some play money at the stock, but quickly sell when it drops and move on.
I do have my exit strategy set for both good or bad scenarios.
I was just thinking to myself that the posters here who pump when the stock is up and bash when it's down can get a new nickname. I shall call them "troller coasters". Happy investing:)
Where is this info found? I see no PR
Nah. US holiday weekend and anything new posted would be beating a dead horse. Not that it has stopped others before. I'm still waiting for George Washington to come down my chimney and hide a basket full of candy and fireworks. There is no better way to celebrate anything than to mindlessly blow stuff up.
Thanks for the article. Helps put things in perspective. Especially since cydy has only done around 200 million of fund raising and NP has been CEO around 7ish years. Their pace is pretty good. Granted progenics started the process. The timeline is pretty close to on par with expenditures way under(yay). If they get approval, it will be impressive given the stats on that article about how many drugs make it.
Saw a commercial last night for a once a week injection for diabetes. (Don't remember the name since most drugs use quite the mix of alphabetical characters) Perhaps a start get the mindset away from taking pills as the only method for taking medicine.
Whoa there kemosabe. You don't want facts to get in the way of a good old fashioned NP rant. Why listen to the CEO who actually knows the ins and outs of the company instead of random message board speculation? It's ok, I'll let it slide. But just this once.
Maybe the TO is why the open market volume has all but dried up. 10k so far this morning? I can get 1.5 shares for cheaper than current price if I had warrants. Maybe that's why the other to only did just ok. Market price and warrant price were pretty much the same. Half share extra didn't excite anyone. Now mkt is above exercise price. Obviously speculation only....and positive thinking. Negative thinking says there's just no interest in cydy last couple days.
Some good points. Like a talented football team winning pct at 500 and everyone saying they are better than that. Maybe they are but the record says otherwise.
I do believe cydy is better than their record, but based on the number of YouTube hits the interviews get and the fact it was mentioned on the other board that the shareholder meeting had people asking basic questions that if they just followed the company they would already know.(and these people are investors?)
Some investors don't pay attention.
Those that do are in disbelief of the price. At the end of the day supply and demand rule the roost. Lack of awareness leaves few buyers at the table. Until cydy is on people's radar we will probably remain in in 40-50 cent limbo. I don't think science news will get us there as quickly(or at all) as much as a deal with a well known entity. That brings more new eyes to the table and perks up the interest of institutions.
For patients sake I want to see cydy thrive and for my pocket book. I do think there is some floor here as Samsung has said they want to help cydy succeed whatever that entails.
Until then, we're in the OTC doldrums waiting to watch this story unfold. Hopefully before everyone gets too impatient and heads for the exits.
Even though everyone has a right to their own opinion, I am glad many here are not the CEO, even though some seem to be armchair CEOs. Claiming cydy is not focused enough on HIV combo? They've done all they can do. They wait on the government entity now to know which results the FDA will accept(525/700)? Should they be resting on their laurels and twiddling their thumbs spending no money at all while other biotechs past them by? We need diversity, plans a, b and c. Less chance of all failing. In Nash, what does it hurt to do a few trials? If it comes out not so good, don't pursue any further, but to suggest not even trying? Oh cancer is too tough let's not try that one, too many pharma failures. When I have a project at work and I need directions from upper MGMT on how to proceed, I don't sit around staring at my inbox waiting for a reply. I create value for the company by working on other projects until I get what I need for the higher priority project. I see people say cydy sure issues a lot of press releases. More probably than most biotechs I know. Probably because most small biotechs have one maybe 2 indications and results of progress are further apart. Granted some PRs feel like fluff pieces but each one indicates progress being made for potentially more value. We all think differently, but sometimes the logic in the room baffles me. Maybe because I'm a programmer and my entire day is centered around logic. Happy investing! (PS I'm glad I'm not CEO either, all the jetsettng NP has to do and all the criticism he probably reads for any perceived or actual mistake...props to him. I prefer hiding in my cubicle and posting anonymously on message boards)